RRM1 and small cell lung carcinoma: Although previous studies have investigated RRM1 expression in SCLC specimens to predict the efficacy of DNA biosynthesis inhibitors, such as cisplatin, carboplatin, etoposide, and gemcitabine24–26, the biological role of RRM1 in SCLC has not been addressed until now.